Moreover, we discovered that PTPN6 regulated tumor progression by reducing immune cell infiltration and inhibiting immune response, indicating that PTPN6 could be a therapeutic target for cancer immunotherapy in GBM. The gene discussed is PTPN6; the disease is cancer.